Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelsey S Johnson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Non-Coding RNA|August 27, 2021
Nanoliposomal Delivery of MicroRNA-203 Suppresses Migration of Triple-Negative Breast Cancer through Distinct Target SuppressionShuxuan Song, Kelsey S Johnson, Henry Lujan, et al.
Cancers|January 11, 2022
CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial-Mesenchymal Gene ExpressionKelsey S Johnson, Shaimaa Hussein, Priyanka Chakraborty, et al.
Oncotarget|October 15, 2017
The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transitionJoseph H Taube, Nathalie Sphyris, Kelsey S Johnson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Non-Coding RNA|August 27, 2021
Nanoliposomal Delivery of MicroRNA-203 Suppresses Migration of Triple-Negative Breast Cancer through Distinct Target SuppressionShuxuan Song, Kelsey S Johnson, Henry Lujan, et al.
Cancers|January 11, 2022
CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial-Mesenchymal Gene ExpressionKelsey S Johnson, Shaimaa Hussein, Priyanka Chakraborty, et al.
Oncotarget|October 15, 2017
The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transitionJoseph H Taube, Nathalie Sphyris, Kelsey S Johnson, et al.
Pageof 1